Skip to content

AST-120 for decreasing circulating protein-bound uremic toxins in hemodialysis patients.

AST-120 for decreasing circulating protein-bound uremic toxins in hemodialysis patients. - AST-120 for decreasing circulating protein-bound uremic toxins in hemodialysis patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000009618
Enrollment
20
Registered
2013-01-01
Start date
2013-01-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease undergoing hemodialysis treatment.

Interventions

Use of AST-120 Not use of AST-120

Sponsors

Niigata University Graduate School of Medical and Dental Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Maintenance hemodialysis patients

Exclusion criteria

Exclusion criteria: Patients who need hospitalization with complications

Design outcomes

Primary

MeasureTime frame
Reducing the level of circulating protein-bound uremic toxins.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026